Genmab A/S Stock

Genmab A/S EBITDA per Employee

The EBITDA per Employee of Genmab A/S (GMAB.CO) as of Jul 22, 2026 is 2.28 M USD. In the previous year, EBITDA per Employee was 1.85 M USD — a change of 23.34% (higher).

EBITDA per Employee

2.28 MUSD

YoY

23.34%

Last updated:

EBITDA per Employee of Genmab A/S is 2026 2.28 M USD. EBITDA per Employee of Genmab A/S was 2025 1.85 M USD. It decreases by 23.34% higher compared to the previous year.
Access this data via the Eulerpool API

Genmab A/S Stock analysis

What does Genmab A/S do? Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab A/S stock

EBITDA per Employee of Genmab A/S is 2.28 M USD in 2026.

Access this data via the Eulerpool API

Workforce — Genmab A/S

All Key Metrics — Genmab A/S